Baxter's Robert Parkinson - CEO Pay
Baxter - Robert Parkinson
Total Compensation: $17.6M
2007 Revenue: $11.3B
2006 Revenue: $10.4B
Change: 8.6%
Details: Parkinson's $17.6 million haul was driven primarily by strong company and individual performance in 2007 and 2006. According to the company's proxy statement, Parkinson's compensation "reflects the role he has played in the turnaround of the company since his arrival in 2004." Parkinson gained $1.29M in base salary, $3.75M in stock option awards, and $2.28 in additional pension.
Baxter News:
Baxter: Fake heparin predated API
Baxter recalls heparin on adverse events
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets